MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Bay City Capital
Finance & Acquisition: Bay City
*Portfolio Companies: Bay City
Intarcia Therapeutics, Inc.
Organization & Developments: Intarcia
Parents
Intarcia Therapeutics, Inc.
Children
2010: Intarcia Bets It Will Shake Up Diabetes Treatment With Implantable Device (2010)
2010: The company started on this track about five years ago when it obtained a license to technology from Alza (now part of Johnson & Johnson) (2010)
2016: Gates Foundation Commits Up to $140 Million to Intarcia for HIV Prevention
2016: Intarcia's proprietary Medici Drug Delivery System, a matchstick-size device that is implanted under the skin and continuously releases medicine, enabling optimal adherence
Attempting to tackle diabetes in an unorthodox drug/device combination strategy.
Biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeuti
For the treatment of cancer and infectious diseases.
Intarcia’s key technology, called Duros, is a matchstick-sized implantable mini pump that is supposed to slowly, steadily secrete a precise amount of any drug in the body.
The plan was to further develop an intriguing platform to deliver drugs in an efficient new way.
Jumps
*Key People: Intarcia
Finance & Acquisitions: Intarcia